NodThera
www.nodthera.comNodThera is developing a new class of potent and highly selective NLRP3 inflammasome inhibitors for the treatment of diseases driven by chronic inflammation. We’re building a dynamic team of people across our offices in Cambridge, UK; Seattle, WA; and Lexington, MA; all united by our shared ambition, enthusiasm, and creativity.
Read more
NodThera is developing a new class of potent and highly selective NLRP3 inflammasome inhibitors for the treatment of diseases driven by chronic inflammation. We’re building a dynamic team of people across our offices in Cambridge, UK; Seattle, WA; and Lexington, MA; all united by our shared ambition, enthusiasm, and creativity.
Read more
Country
State
Massachusetts
City (Headquarters)
Lexington
Industry
Employees
11-50
Founded
2016
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Scientific Officer
Email ****** @****.comPhone (***) ****-****Interim Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Senior Director of Medicinal Chemistry
Email ****** @****.comPhone (***) ****-****Senior Director of Portfolio and Project Management
Email ****** @****.comPhone (***) ****-****
Technologies
(1)
Reach decision makers at NodThera
Free credits every month!
NodThera FAQ
Lexington, United States
Biotechnology Research
